![100+ companies will participate in CED’s Venture Connect – here’s who made the cut](https://www.geneventiv.com/wp-content/uploads/2021/02/venture-connect-2021-e1611941919782.png)
![100+ companies will participate in CED’s Venture Connect – here’s who made the cut](https://www.geneventiv.com/wp-content/uploads/2021/02/venture-connect-2021-e1611941919782.png)
Recent Posts
- GeneVentiv Welcomes New Scientific Advisory Board Member, Sylvia Fong
- GeneVentiv Therapeutics Awarded $2.5 Million SBIR Grant to Advance Gene Therapy for All Hemophilias, with or without Inhibitors
- New partners to develop universal gene therapy for hemophilia
- ReciBioPharm and GeneVentiv Therapeutics partner to advance first AAV-based gene therapy for haemophilia patients with inhibitors
- GeneVentiv to Attend BIO CEO & Investor Conference
Recent Comments